Dosage forms and related therapies
CA 2496411 A1 · Owner: Philera New Zealand Limited · Inventors: Baker, John Richard; Beeley, Nigel Robert Arnold; Cooper, Garth James Smith
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention is directed in part to novel doses dosage formulations, and , routes of administration of such doses and dose formulations said dose and , dose formulations containing one or more copper chelators for example, one or , more trientine active agents including trientine analogues, trientine salts trientine prodrugs, and trientine derivatives useful in the treatment of , diseases, disorders and conditions including in indications where copper may play a role.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 20, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 20, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 20, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.